Alogliptin Benzoate/Metformin Hydrochloride
- Generic Name
- Alogliptin Benzoate/Metformin Hydrochloride
A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Celltrion
- Target Recruit Count
- 48
- Registration Number
- NCT05363384
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS
Phase 4
Completed
- Conditions
- Polycystic Ovary SyndromeInsulin Resistance
- Interventions
- First Posted Date
- 2016-02-17
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 30
- Registration Number
- NCT02683226
- Locations
- 🇸🇮
University Medical Center Ljubljana, Ljubljana, Slovenia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath